Medifast

Traded on the St. Petersburg Stock Exchange
Medifast is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics. The company owns five subsidiaries: Jason Pharmaceuticals, Take Shape for Life, Jason Enterprises, Jason Properties, Seven Crondall.
Medifast stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Medifast balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Medifast cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Medifast multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Medifast profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Medifast assets
Medifast cash flows
Medifast dividends
8.81%

Medifast dividend policy

The company pays dividends quarterly

Medifast shares

TickerNameTypeNominal valueISINPrice
MED:USMedifast, Inc.Common share-US58470H1014$34.7
Medifast news
17.06.2022
The Medifast Board of Directors announced a quarterly dividend of $1.64 per share. The last day to buy securities to receive the dividend is June 23, 2022. The annual dividend yield may reach 3.21%.
03.05.2022
Medifast's GAAP net income for 3 months of 2022 was $41.781 million, up 1.7% from $41.063 million in the prior year. Revenue increased 22.6% to $417.6 million from $340.669 million a year earlier.
18.03.2022
The Medifast Board of Directors announced a quarterly dividend of $1.64 per share. The last day to buy securities to receive the dividend is March 24, 2022. The annual dividend yield may reach 2.77%.
24.02.2022
Net income of Medifast under GAAP for 2021 was $164.031 million, up 59.5% from $102.859 million in the previous year. Revenue increased 63.2% to $1.526 billion from $0.935 billion a year earlier.
General information
Company nameMedifast
SectorHealth Care / Health Care Equipment & Services / Health Care Providers & Services / Health Care Services
Business address11445 CRONHILL DRIVE OWINGS MILLS MD 21117 7327640619
Mailing address11445 CRONHILL DRIVE OWINGS MILLS MD 21117
Websiteir.medifastinc.com
Information disclosurewww.sec.gov